ENTITY
WuXi PharmaTech Cayman

WuXi PharmaTech Cayman (WX US)

42
Analysis
Health Care • China
WuXi PharmaTech (Cayman), Inc. provides research services. The Company offers services include researching, analysis, development, and manufacturing of pharmaceutical and biotechnology products.
more
bearish•XtalPi
•10 Jun 2025 09:48

Xtalpi US$860m IPO Lockup Expiry - Last of the Lockup Release with Nearly All Shares in CCASS Now

XtalPi Holdings (2228 HK) was listed in Hong Kong on 13th Jun 2024 after raising US$126m. Its one-year lockup will expire soon.

Logo
1k Views
Share
bullish•Giant Biogene
•16 Apr 2025 19:01

Giant Biogene Placement - Great Track Record but Previous Deal Didn’t Do Well

Giant Biogene (2367 HK) aims to raise up to US$250m via a top-up placement. In this note, we talk about the deal dynamics and run the deal through...

Logo
648 Views
Share
bullish•WuXi XDC
•01 Apr 2025 19:11

Wuxi XDC Placement - Following Biologics Playbook, past Deals Have Been Mixed

WuXi AppTec (2359 HK) aims to raise around US$250m via selling around 3.5% stake in WuXi XDC Cayman (2268 HK). In this note, we talk about the deal...

Logo
586 Views
Share
bullish•XtalPi
•18 Feb 2025 19:08

Xtapli Placement - Questionable Timing. An AI Momentum Play, at Best

Xtapli is looking to raise around US$242m via a primary placement, after having raised US$145m in Jan 2025. In this note, we talk about the deal...

Logo
633 Views
Share
bullish•Bloks Group
•13 Jan 2025 08:44

ECM Weekly (13th Jan 2025) - LG CNS, Bloks, Guming, Crizac, Shift Up, Adani, Wuxi

Aequitas Research's weekly update on the IPOs, placements, lockup expiry and other ECM linked events that were covered by the team over the past week.

Logo
716 Views
Share
x